title: Posterior reversible encephalopathy syndrome in alcoholic hepatitis: Hepatic encephalopathy a common theme.
abstract: Posterior reversible encephalopathy syndrome (PRES) is a neuro-radiologic diagnosis that has become more widely recognized and reported over the past few decades. As such, there are a number of known risk factors that contribute to the development of this syndrome, including volatile blood pressures, renal failure, cytotoxic drugs, autoimmune disorders, pre-eclampsia, and eclampsia. This report documents the first reported case of PRES in a patient with severe alcoholic hepatitis with hepatic encephalopathy and delves into a molecular pathophysiology of the syndrome.
authors.affiliation: Elizabeth S John, Ramy Sedhom, Ishita Dalal, Ranita Sharma, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, United States.
authors.forename: Elizabeth S
authors.initials: ES
authors.lastname: John
authors.affiliation: Elizabeth S John, Ramy Sedhom, Ishita Dalal, Ranita Sharma, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, United States.
authors.forename: Ramy
authors.initials: R
authors.lastname: Sedhom
authors.affiliation: Elizabeth S John, Ramy Sedhom, Ishita Dalal, Ranita Sharma, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, United States.
authors.forename: Ishita
authors.initials: I
authors.lastname: Dalal
authors.affiliation: Elizabeth S John, Ramy Sedhom, Ishita Dalal, Ranita Sharma, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, United States.
authors.forename: Ranita
authors.initials: R
authors.lastname: Sharma
mesh_terms: D000081:Acetamides / Q000627:therapeutic use; D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D001201:Ascites / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D001921:Brain / Q000000981:diagnostic imaging*; D004569:Electroencephalography; D005260:Female; D005765:Gastrointestinal Agents; D006501:Hepatic Encephalopathy / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006519:Hepatitis, Alcoholic / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D000078334:Lacosamide; D007792:Lactulose / Q000627:therapeutic use; D008111:Liver Function Tests; D008279:Magnetic Resonance Imaging; D010349:Patient Compliance; D054038:Posterior Leukoencephalopathy Syndrome / Q000097:blood / Q000150:complications* / Q000175:diagnosis*; D011247:Pregnancy; D011859:Radiography; D012294:Rifamycins / Q000627:therapeutic use; D000078262:Rifaximin; D012640:Seizures / Q000188:drug therapy / Q000209:etiology; D012709:Serum Albumin / Q000032:analysis
chemical_list: D000081:Acetamides; D000927:Anticonvulsants; D005765:Gastrointestinal Agents; D012294:Rifamycins; D012709:Serum Albumin; D007792:Lactulose; D000078334:Lacosamide; D000078262:Rifaximin
keywords: Alcoholic hepatitis; Headaches; Hepatic encephalopathy; Posterior reversible encephalopathy syndrome; Seizure